TXNRD1 and chronic obstructive pulmonary disease: Metabolic reprogramming can regulate the expression of metabolism-related genes (e.g., thioredoxin reductase 1, TXNRD1), which exerts redox/antioxidant regulatory functions and participates in COPD-related metabolic disturbance processes by regulating redox balance (115).